Cellulitis: Difference between revisions

No edit summary
No edit summary
Line 39: Line 39:
== Medications  ==
== Medications  ==


Cephalexin, Dicloxacillin, Penicillin VK, Amoxicillin, and Clindamycin are typical Antistreptococcal Antimicrobial agents for the treatment of typical cellulits that is considered mild and does not show signs of systemic involvement. <br>
Cephalexin, Dicloxacillin, Penicillin VK, Amoxicillin, and Clindamycin are typical Antistreptococcal Antimicrobial agents for the treatment of typical cellulits that is considered mild and does not show signs of systemic involvement. <ref name="Raff" /><br>


== Diagnostic Tests/Lab Tests/Lab Values  ==
== Diagnostic Tests/Lab Tests/Lab Values  ==

Revision as of 02:29, 11 April 2017

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Definition/Description[edit | edit source]

Cellulitis is a localized bacterial skin infection, which typically affects the lower limbs but can occur on any area of skin and underlying subcutaneous tissue &nbsp;It is characterized by acute onset of&nbsp;redness, inflammation, pain, and swelling of the affected area. Accompanying symptoms include generalized fever, rigors, nausea, and vomiting.[1]

The infection is most commonly caused by B-Hemolytic Streptococci bacteria and reoccurs up to 50% of the time in the lower extremity.[2] Most individuals diagnosed with cellulitis have a low risk of severe complications but few suffers can have severe sepsis, local gangrene, and/or necrotising fasciitis.[1]

Mild cellulitis.jpg

A mild case of cellulitis[3]

Severe cellulitis.jpg

A severe case of cellulitis that developed under a cast[3]

Prevalence[edit | edit source]

  • 650,000 hospital admissions per year in the United States are due to cellulitis.[4]
  • When hospitalized, patients with recurrent cellulitis require longer hospitalizations relative to nonrelapsing cellulitis patients.[5]
  • From 1998-2006, 10% of all infectious-disease hospitalizations were related to cellulitis[5]
  • 22-49% of patients who have cellulitis report at least one previous episode[5]
  • Recurrences, typically in the same location, occur approximately 14% of cellulitis cases within 1 year and in 45% of cases within 3 years[5]


Characteristics/Clinical Presentation[edit | edit source]

Typical symptoms include acute poorly demarcated and spreading erythema along with pain, swelling, and warmth of the lower extremity but can occur on any area of skin or underlying subcutaneous tissue.[2][5] Additional symptoms may include fever, nausea, vomiting, and rigors[5].[6]Other features include proximal dilated and edematous skin lymphatics and bulla formation. Cellulitis predominantly has a unilateral presentation, most commonly in the lower extremity.[5]

Classic presentation of cellulitis: poorly demarcated erythema[7]

Associated Co-morbidities[edit | edit source]

Diabetes Mellitus is one of most common comorbidities among those hospitalized for acute bacterial infections including cellulitis.
Following a cellulitis infection, those with diabetes require a longer course of antibiotic therapy and are more likely to have an outpatient follow up visit.[8]

Lymphatic flow changes can predispose individuals to a cutaneous infection. Examples of co-morbidities that result in lymphatic flow changes include peripheral vascular disease, liposuction, radiation therapy, lymph node dissection,' and lymphedema

Medications[edit | edit source]

Cephalexin, Dicloxacillin, Penicillin VK, Amoxicillin, and Clindamycin are typical Antistreptococcal Antimicrobial agents for the treatment of typical cellulits that is considered mild and does not show signs of systemic involvement. [5]

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

add text here

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: addfeedhere|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.

  1. 1.0 1.1 Cite error: Invalid <ref> tag; no text was provided for refs named Mason
  2. 2.0 2.1 Cite error: Invalid <ref> tag; no text was provided for refs named Tsai
  3. 3.0 3.1 Medscape. Cellulitis. http://emedicine.medscape.com/article/214222-overview (accessed 27 Feb 2017).
  4. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016;316(3):325-37. http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/jama/935437/ (accessed 27 Feb 2017).
  5. 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 Cite error: Invalid <ref> tag; no text was provided for refs named Raff
  6. Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for cellulitis and erysipelas. (Cochrane review). Cochrane Database Syst Rev. 2010(6):CD004299.
  7. Bailey E, Kroshinsky D. Cellulitis: Diagnosis and Management. Dermatologic Therapy. 2011;24:229–39.http://onlinelibrary.wiley.com/doi/10.1111/j.1529-8019.2011.01398.x/full (accessed 15 Mar 2017).
  8. Jenkins TC. Comparison of the Microbiology and Antibiotic Treatment among Diabetic and Non-Diabetic Patients Hospitalized for Cellulitis or Cutaneous Abscess. J Hosp Med. 9ADADDec12;:788–94.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256165/ (accessed 28 Feb 2017).